<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>rheumatology</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>rheumatology | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="A genome-wide association study suggests new susceptibility loci for primary antiphospholipid syndrome
Authors: Casares-Marfil, D.; Martinez-Bueno, M.; Borghi, M. O.; Pons-Estel, G.; PRECISESADS Clinical Consortium, ; Reales, G.; Zuo, Y.; Espinosa, G.; Radstake, T. R. D. J.; van den Hoogen, L. L.; Wallace, C.; Guthridge, J.; James, J.; Cervera, R.; Luigi Meroni, P. L.; Martin, J.; Knight, J.; Alarcon-Riquelme, M.; Sawalha, A. H.
Score: 6.5, Published: 2023-12-05 DOI: 10.1101/2023.12.05.23299396">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/rheumatology/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="rheumatology" />
<meta property="og:description" content="A genome-wide association study suggests new susceptibility loci for primary antiphospholipid syndrome
Authors: Casares-Marfil, D.; Martinez-Bueno, M.; Borghi, M. O.; Pons-Estel, G.; PRECISESADS Clinical Consortium, ; Reales, G.; Zuo, Y.; Espinosa, G.; Radstake, T. R. D. J.; van den Hoogen, L. L.; Wallace, C.; Guthridge, J.; James, J.; Cervera, R.; Luigi Meroni, P. L.; Martin, J.; Knight, J.; Alarcon-Riquelme, M.; Sawalha, A. H.
Score: 6.5, Published: 2023-12-05 DOI: 10.1101/2023.12.05.23299396" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/rheumatology/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2023-12-13T10:39:57+00:00" />
<meta property="article:modified_time" content="2023-12-13T10:39:57+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="rheumatology"/>
<meta name="twitter:description" content="A genome-wide association study suggests new susceptibility loci for primary antiphospholipid syndrome
Authors: Casares-Marfil, D.; Martinez-Bueno, M.; Borghi, M. O.; Pons-Estel, G.; PRECISESADS Clinical Consortium, ; Reales, G.; Zuo, Y.; Espinosa, G.; Radstake, T. R. D. J.; van den Hoogen, L. L.; Wallace, C.; Guthridge, J.; James, J.; Cervera, R.; Luigi Meroni, P. L.; Martin, J.; Knight, J.; Alarcon-Riquelme, M.; Sawalha, A. H.
Score: 6.5, Published: 2023-12-05 DOI: 10.1101/2023.12.05.23299396"/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "rheumatology",
      "item": "https://trxiv.yorks0n.com/posts/rheumatology/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "rheumatology",
  "name": "rheumatology",
  "description": "A genome-wide association study suggests new susceptibility loci for primary antiphospholipid syndrome\nAuthors: Casares-Marfil, D.; Martinez-Bueno, M.; Borghi, M. O.; Pons-Estel, G.; PRECISESADS Clinical Consortium, ; Reales, G.; Zuo, Y.; Espinosa, G.; Radstake, T. R. D. J.; van den Hoogen, L. L.; Wallace, C.; Guthridge, J.; James, J.; Cervera, R.; Luigi Meroni, P. L.; Martin, J.; Knight, J.; Alarcon-Riquelme, M.; Sawalha, A. H.\nScore: 6.5, Published: 2023-12-05 DOI: 10.1101/2023.12.05.23299396",
  "keywords": [
    
  ],
  "articleBody": " A genome-wide association study suggests new susceptibility loci for primary antiphospholipid syndrome\nAuthors: Casares-Marfil, D.; Martinez-Bueno, M.; Borghi, M. O.; Pons-Estel, G.; PRECISESADS Clinical Consortium, ; Reales, G.; Zuo, Y.; Espinosa, G.; Radstake, T. R. D. J.; van den Hoogen, L. L.; Wallace, C.; Guthridge, J.; James, J.; Cervera, R.; Luigi Meroni, P. L.; Martin, J.; Knight, J.; Alarcon-Riquelme, M.; Sawalha, A. H.\nScore: 6.5, Published: 2023-12-05 DOI: 10.1101/2023.12.05.23299396\nObjectivesPrimary antiphospholipid syndrome (PAPS) is a rare autoimmune disease characterized by the presence of antiphospholipid antibodies and the occurrence of thrombotic events and pregnancy complications. Our study aimed to identify novel genetic susceptibility loci associated with PAPS. MethodsWe performed a genome-wide association study comprising 5,485 individuals (482 affected individuals) of European ancestry. Significant and suggestive independent variants from a meta-analysis of approximately 7 million variants were evaluated for functional and biological process enrichment. The genetic risk variability for PAPS in different populations was also assessed. Hierarchical clustering, Mahalanobis distance, and Dirichlet Process Mixtures with uncertainty clustering methods were used to assess genetic similarities between PAPS and other immune-mediated diseases. ResultsWe revealed genetic associations with PAPS in a regulatory locus within the HLA class II region near HLA-DRA and in STAT4 with a genome-wide level of significance. 34 additional suggestive genetic susceptibility loci for PAPS were also identified. The disease risk allele in the HLA class II locus is associated with overexpression of HLA-DRB6, HLA-DRB9, HLA-DPB2, HLA-DQA2 and HLA-DQB2, and is independent of the association between PAPS and HLA-DRB1*1302. Functional analyses highlighted immune and nervous system related pathways in PAPS-associated loci. The comparison with other immune-mediated diseases revealed a close genetic relatedness to neuromyelitis optica, systemic sclerosis, and Sjogrens syndrome, suggesting colocalized causal variations close to STAT4, TNPO3, and BLK. ConclusionsThis study represents a comprehensive large-scale genetic analysis for PAPS and provides new insights into the genetic basis and pathophysiology of this rare disease.\nHaloperidol inhibits inflammasome activation via LAMTOR1 and reduces the risk of arthritides\nAuthors: Ambati, V.; Yerramothu, P.; Konduri, R.; Nguyen, J.; Gelfand, B. D.; Werner, B. C.; Taylor, E. W.; Wang, S.-b.\nScore: 1.2, Published: 2023-12-08 DOI: 10.1101/2023.12.06.23299609\nGout is the most prevalent form of inflammatory arthritis in the world. Although multiple treatments exist, many patients are poorly responsive. Here we report, using a health insurance database analysis, that use of the anti-psychotic haloperidol is associated with a reduced risk of incident gout. Haloperidol inhibits ASC speck formation, caspase-1 activation, and release of IL-1{beta} and IL-6, suggesting that it inhibits NLRP3 inflammasome activation and downstream cytokine responses. We also identified LAMTOR1 as a novel binding partner for haloperidol and demonstrate that haloperidol inhibits the aggregation of LAMTOR1 and NLRP3. Since NLRP3 inflammasome activation has been implicated in gout, these data provide a foundation for exploring haloperidol as a potential therapy.\n",
  "wordCount" : "462",
  "inLanguage": "en",
  "datePublished": "2023-12-13T10:39:57Z",
  "dateModified": "2023-12-13T10:39:57Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/rheumatology/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      rheumatology
    </h1>
    <div class="post-meta">&lt;span&gt;updated on December 13, 2023&lt;/span&gt;

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.12.05.23299396">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.12.05.23299396" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.12.05.23299396">
        <p class="paperTitle">A genome-wide association study suggests new susceptibility loci for primary antiphospholipid syndrome</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.12.05.23299396" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.12.05.23299396" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Casares-Marfil, D.; Martinez-Bueno, M.; Borghi, M. O.; Pons-Estel, G.; PRECISESADS Clinical Consortium,  ; Reales, G.; Zuo, Y.; Espinosa, G.; Radstake, T. R. D. J.; van den Hoogen, L. L.; Wallace, C.; Guthridge, J.; James, J.; Cervera, R.; Luigi Meroni, P. L.; Martin, J.; Knight, J.; Alarcon-Riquelme, M.; Sawalha, A. H.</p>
        <p class="info">Score: 6.5, Published: 2023-12-05 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.12.05.23299396' target='https://doi.org/10.1101/2023.12.05.23299396'> 10.1101/2023.12.05.23299396</a></p>
        <p class="abstract">ObjectivesPrimary antiphospholipid syndrome (PAPS) is a rare autoimmune disease characterized by the presence of antiphospholipid antibodies and the occurrence of thrombotic events and pregnancy complications. Our study aimed to identify novel genetic susceptibility loci associated with PAPS.

MethodsWe performed a genome-wide association study comprising 5,485 individuals (482 affected individuals) of European ancestry. Significant and suggestive independent variants from a meta-analysis of approximately 7 million variants were evaluated for functional and biological process enrichment. The genetic risk variability for PAPS in different populations was also assessed. Hierarchical clustering, Mahalanobis distance, and Dirichlet Process Mixtures with uncertainty clustering methods were used to assess genetic similarities between PAPS and other immune-mediated diseases.

ResultsWe revealed genetic associations with PAPS in a regulatory locus within the HLA class II region near HLA-DRA and in STAT4 with a genome-wide level of significance. 34 additional suggestive genetic susceptibility loci for PAPS were also identified. The disease risk allele in the HLA class II locus is associated with overexpression of HLA-DRB6, HLA-DRB9, HLA-DPB2, HLA-DQA2 and HLA-DQB2, and is independent of the association between PAPS and HLA-DRB1*1302. Functional analyses highlighted immune and nervous system related pathways in PAPS-associated loci. The comparison with other immune-mediated diseases revealed a close genetic relatedness to neuromyelitis optica, systemic sclerosis, and Sjogrens syndrome, suggesting colocalized causal variations close to STAT4, TNPO3, and BLK.

ConclusionsThis study represents a comprehensive large-scale genetic analysis for PAPS and provides new insights into the genetic basis and pathophysiology of this rare disease.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.12.06.23299609">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.12.06.23299609" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.12.06.23299609">
        <p class="paperTitle">Haloperidol inhibits inflammasome activation via LAMTOR1 and reduces the risk of arthritides</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.12.06.23299609" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.12.06.23299609" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Ambati, V.; Yerramothu, P.; Konduri, R.; Nguyen, J.; Gelfand, B. D.; Werner, B. C.; Taylor, E. W.; Wang, S.-b.</p>
        <p class="info">Score: 1.2, Published: 2023-12-08 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.12.06.23299609' target='https://doi.org/10.1101/2023.12.06.23299609'> 10.1101/2023.12.06.23299609</a></p>
        <p class="abstract">Gout is the most prevalent form of inflammatory arthritis in the world. Although multiple treatments exist, many patients are poorly responsive. Here we report, using a health insurance database analysis, that use of the anti-psychotic haloperidol is associated with a reduced risk of incident gout. Haloperidol inhibits ASC speck formation, caspase-1 activation, and release of IL-1{beta} and IL-6, suggesting that it inhibits NLRP3 inflammasome activation and downstream cytokine responses. We also identified LAMTOR1 as a novel binding partner for haloperidol and demonstrate that haloperidol inhibits the aggregation of LAMTOR1 and NLRP3. Since NLRP3 inflammasome activation has been implicated in gout, these data provide a foundation for exploring haloperidol as a potential therapy.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2023 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        Â· Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
